Search

Your search keyword '"Brenner, Nicole"' showing total 247 results

Search Constraints

Start Over You searched for: Author "Brenner, Nicole" Remove constraint Author: "Brenner, Nicole"
247 results on '"Brenner, Nicole"'

Search Results

1. Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 Years

3. Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis

4. Detection of stage I HPV-driven oropharyngeal cancer in asymptomatic individuals in the Hamburg City Health Study using HPV16 E6 serology – A proof-of-concept study

5. Serological Assessment of 18 Pathogens and Risk of AIDS-Associated Non-Hodgkin Lymphoma

9. Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomization

11. Sacral Arteriovenous Fistula Causing Myelopathy: Embolization with Obliteration of the Fistula, Recurrence of the Arteriovenous Shunt, Second Embolization with Complete Obliteration of the Fistula and Excellent Clinical Outcome, but Secondary Development of a Gait Disorder

14. Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

17. Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 Years

18. Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage

19. Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk

20. Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer

22. Epstein Barr virus antibody reactivity and gastric cancer: A population-based case-control study

26. Supplementary Table 3 from Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

27. Supplementary Figure 1 from Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

28. Supplementary Methods from Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

29. Supplementary Figure 4 from Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

30. Supplementary Table 2 from Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

31. Associations of genetic and infectious risk factors with coronary heart disease

32. A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers

33. Author response: Associations of genetic and infectious risk factors with coronary heart disease

34. Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium

35. Associations of genetic and infectious risk factors with coronary heart disease

36. Additional file 6 of The combined impact of persistent infections and human genetic variation on C-reactive protein levels

37. Additional file 7 of The combined impact of persistent infections and human genetic variation on C-reactive protein levels

38. Additional file 2 of The combined impact of persistent infections and human genetic variation on C-reactive protein levels

39. Additional file 3 of The combined impact of persistent infections and human genetic variation on C-reactive protein levels

40. Additional file 5 of The combined impact of persistent infections and human genetic variation on C-reactive protein levels

41. Additional file 1 of The combined impact of persistent infections and human genetic variation on C-reactive protein levels

42. Additional file 4 of The combined impact of persistent infections and human genetic variation on C-reactive protein levels

44. HPV16 E6‐antibody associated risk of oropharyngeal cancer increases by calendar‐time: A nested case‐control study.

47. Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis—a presymptomatic case–control study

48. Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomization

49. Seroprevalence of Chlamydia trachomatis, herpes simplex 2, Epstein-Barr virus, hepatitis C and associated factors among a cohort of men ages 18–70 years from three countries

Catalog

Books, media, physical & digital resources